The Role of REV-ERB Receptors in Cancer Pathogenesis

Area of Science:

• Molecular Biology
• Chronobiology
• Cancer Research

Background:

• REV-ERB receptors are nuclear receptors and transcription factors regulating gene expression.
• They play a key role in peripheral circadian rhythmicity through feedback loops with clock genes.
• REV-ERB expression is often downregulated in various cancers and linked to cancer-associated cachexia.

Purpose of the Study:

• To review the role of REV-ERB receptors in cancer pathogenesis and associated systemic effects.
• To highlight the potential of pharmacological restoration of REV-ERB activity.
• To identify the need for further mechanistic studies on REV-ERB-mediated circadian deregulation in cancer.

Main Methods:

• Review of existing literature on REV-ERB receptors, circadian rhythms, and cancer.
• Analysis of studies reporting REV-ERB expression levels in cancerous tissues.
• Examination of preclinical data on synthetic REV-ERB agonists.

Main Results:

• REV-ERB expression is downregulated in the majority of studied cancer types.
• Dysregulation of REV-ERBs is implicated in the development of cancer-associated cachexia.
• Synthetic agonists show potential for restoring REV-ERB function, but data is limited.

Conclusions:

• REV-ERB receptors are critical regulators of circadian rhythms with implications in cancer.
• Further mechanistic research is needed to understand REV-ERB's role in carcinogenesis and cachexia.
• Targeting REV-ERBs may offer novel therapeutic strategies for cancer and related systemic complications.